Dantrium and condition aggravated Patient Reports February 13, 2012

Dantrium Side Effects Report #4589342-7
Dantrium side effect was reported by a Consumer or non-health professional from on Feb 02, 2005. Male patient, 39 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with Dantrium. After drug was administered, patient experienced the following side effects: condition aggravated, pleural effusion, respiratory failure. Dantrium dosage: 100 MG DAILY, IV DRIP. Patient recovered.

Dantrium Side Effects Report #4603638-1
Dantrium side effect was reported by a Physician from on Feb 21, 2005. Male patient, 39 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with Dantrium. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, condition aggravated, eosinophil percentage increased, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased. Dantrium dosage: 100 MG DAILY, IV DRIP. During the same period patient was treated with MIDAZOLAM, PANSPORIN, ZANTAC, FUTHAN, GLUCOSE, KIDMIN, MULTAMIN. Patient was hospitalized. Patient recovered.

Dantrium Side Effects Report #4830981-3
Dantrium side effect was reported by a Physician from JAPAN on Oct 31, 2005. Female patient, 29 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with Dantrium. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, condition aggravated. Dantrium dosage: 80 MG TWICE DAILY, IV NOS. During the same period patient was treated with FAMOTIDINE, CEFOTIAM HYDROCHLORIDE, VITAMEDIN CAPSULE, VISCORIN, FLAVITAN, PARLODEL, DIAZEPAM. Patient was hospitalized. Patient recovered.